[Antiplatelet therapy for acute ischemic stroke].
Tanahashi
Norio
N
Department of Neurology, Saitama Medical University.
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D008689:Methacrylates / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D008689:Methacrylates; D010975:Platelet Aggregation Inhibitors; C034364:ozagrel; D001241:Aspirin; D000077284:Abciximab